QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 限定条件 发表日期：2021     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Site-specific protein modification by 3-n-butylphthalide in primary hepatocytes: Covalent protein adducts diminished by glutathione and N-acetylcysteine 期刊论文 LIFE SCIENCES, 2021, 卷号: 287, 页码: 14 作者:  Xue, Yaru;  Ren, Xuelian;  Zhu, Zhengdan;  Lei, Peng;  Liu, Mengling 收藏  |  浏览/下载：39/0  |  提交时间：2022/01/18 3-n-butylphthalide  Hepatotoxicity  Oxidative stresses  Covalent protein modification  Drug-drug interaction   Single cell Raman spectroscopy to identify different stages of proliferating human hepatocytes for cell therapy 期刊论文 STEM CELL RESEARCH & THERAPY, 2021, 卷号: 12, 期号: 1, 页码: 12 作者:  Ma, Chen;  Zhang, Ludi;  He, Ting;  Cao, Huiying;  Ren, Xiongzhao 收藏  |  浏览/下载：59/0  |  提交时间：2021/12/01 Raman spectroscopy  Cell therapy  Identification  Proliferating human hepatocytes  Dedifferentiation   A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage 期刊论文 METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 卷号: 120, 页码: 12 作者:  Huang, Suling;  Wu, Yanwei;  Zhao, Zhuohui;  Wu, Bing;  Sun, Kai 收藏  |  浏览/下载：90/0  |  提交时间：2021/08/17 Macrophage  NLRP3 inflammasome  Hepatic lipid accumulation  NASH  FXR   Furmonertinib (Alflutinib, AST2818) is a potential positive control drug comparable to rifampin for evaluation of CYP3A4 induction in sandwich-cultured primary human hepatocytes 期刊论文 ACTA PHARMACOLOGICA SINICA, 2021, 页码: 10 作者:  Wu, Ya-li;  Xue, Ya-ru;  Guo, Zi-tao;  Chen, Zhen-dong;  Ge, Xin-yu 收藏  |  浏览/下载：22/0  |  提交时间：2021/08/17 furmonertinib (alflutinib  AST2818)  quantitative proteomics  sandwich-cultured human hepatocytes   Functional Proliferating Human Hepatocytes: In Vitro Hepatocyte Model for Drug Metabolism, Excretion, and Toxicity 期刊论文 DRUG METABOLISM AND DISPOSITION, 2021, 卷号: 49, 期号: 4, 页码: 305-313 作者:  Qiao, Shida;  Feng, Sisi;  Wu, Zhitao;  He, Ting;  Ma, Chen 收藏  |  浏览/下载：26/0  |  提交时间：2021/05/24 SL010110, a lead compound, inhibits gluconeogenesis via SIRT2-p300-mediated PEPCK1 degradation and improves glucose homeostasis in diabetic mice 期刊论文 ACTA PHARMACOLOGICA SINICA, 2021, 页码: 13 作者:  Ren, Yu-ran;  Ye, Yang-liang;  Feng, Ying;  Xu, Ti-fei;  Shen, Yu 收藏  |  浏览/下载：22/0  |  提交时间：2021/05/24 SL010110  gluconeogenesis  primary mouse hepatocytes  PEPCK1  acetylation  degradation